|
May 9
|
Here's Why Novartis (NVS) is a Strong Momentum Stock
|
|
May 8
|
Q1 2025 Schrodinger Inc Earnings Call
|
|
May 8
|
Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
|
|
May 5
|
Novartis (NVS) is a Great Momentum Stock: Should You Buy?
|
|
May 5
|
Why Novartis (NVS) is a Great Dividend Stock Right Now
|
|
Apr 18
|
Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio
|
|
Apr 17
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Apr 17
|
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
|
|
Apr 17
|
Novartis scores NFL deal to tackle health outcomes
|
|
Apr 15
|
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke
|
|
Apr 14
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Apr 14
|
Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Mar 25
|
5 Large Drug Stocks to Watch as Industry Recovers
|
|
Mar 25
|
Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis
|
|
Mar 24
|
Tempero secures $70m to advance addiction treatment candidate
|
|
Mar 24
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Mar 24
|
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
|
|
Mar 22
|
Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli
|
|
Mar 21
|
FDA Approves Novartis Drug for Rare Kidney Disease Treatment
|